Trevi Therapeutics’ Nalbuphine ER Shows Significan...
Category : Clinical Trial Update 23 January 2026Trevi Therapeutics has published positive Phase 2b results from its CORAL trial evaluating oral nalb...
Clinical Trial Update
Insilico Medicine and Hygtia Therapeutics Partner...
Category : Clinical Trial Update 21 January 2026Insilico Medicine and Hygtia Therapeutics have entered an exclusive global license and co-developmen...
Verb Biotics Clinical Trial Shows Probiotic Can Im...
Category : Clinical Trial Update 21 January 2026A new U.S. consumer health survey by Verb Biotics, covering 2,000 adults, found that 73% experience...
CannaLean Completes First-in-Human Study for Oral...
Category : Clinical Trial Update 21 January 2026CannaLean Biotechs Ltd., a clinical-stage biotechnology company, announced the successful completion...
Brenig Therapeutics Advances Two CNS Programs Into...
Category : Clinical Trial Update 20 January 2026Brenig Therapeutics has initiated a first-in-human (FIH) Phase 1 study for BT-409, its brain-selecti...
Latest Newsletter Post
-
Trevi Therapeutics’ Nalbuphine ER S..
23 January 2026
-
HistoIndex Partners with Houston Re..
23 January 2026
-
AGC Biologics Supports Commercial L..
23 January 2026
-
Gillson Sciences Expands into Envir..
23 January 2026
-
Syngene Extends Long-Standing Resea..
22 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com